Evolus Inc (NAS:EOLS)
$ 13.025 0.095 (0.73%) Market Cap: 815.50 Mil Enterprise Value: 839.25 Mil PE Ratio: 0 PB Ratio: 43.42 GF Score: 55/100

Evolus Inc at H C Wainwright Global Investment Conference Transcript

Sep 13, 2021 / 11:00AM GMT
Release Date Price: $8.09 (-0.25%)
Douglas Dylan Tsao
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst

Okay. Welcome, everybody. This is Doug Tsao, I'm a senior analyst at H.C. Wainwright. Up next, we are thrilled to have Evolus presenting, represented by CEO, David Moatazedi; CFO, Lauren Silvernail; as well as VP for Investor Relations, David Erickson.

So with that, we don't have a ton of time, so why don't we just jump right in there.

Questions & Answers

Douglas Dylan Tsao
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst

David, COVID seems to have been a little bit of a mixed bag for the aesthetics industries. On the one hand, it clearly affected doctors' offices as they implemented social distancing, but there was also a Zoom boom, as people spent a lot of time staring themselves on the screen. COVID is proving more persistent than we hoped this spring, but we're obviously not going back to sort of shutdowns either. So perhaps provide some sort of context for everybody in terms of this current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot